Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Dickson

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|May 9, 2019
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)Pradeep Harish, Alberto Malerba, Ngoc Lu-Nguyen, et al.
Nucleic Acids Research|March 18, 2020
G-quadruplex ligands mediate downregulation of DUX4 expressionLukasz Ciszewski, Ngoc Lu-Nguyen, Alex Slater, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 25, 2010
Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx miceAlberto Malerba, Paul S Sharp, Ian R Graham, et al.
Human Gene Therapy|April 2, 2011
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx miceTaeyoung Koo, Alberto Malerba, Takis Athanasopoulos, et al.
Molecular Therapy. Nucleic Acids|December 20, 2012
Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular DystrophyAlberto Malerba, Jagjeet K Kang, Graham McClorey, et al.
Current Gene Therapy|July 11, 2015
Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)Klaudia Kawecka, Michael Theodoulides, Yalin Hasoglu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 29, 2006
APOE epsilon3 gene transfer attenuates brain damage after experimental strokeBarry W McColl, Ailsa L McGregor, Andrew Wong, et al.
Human Molecular Genetics|July 12, 2019
Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1Alberto Malerba, Pierre Klein, Ngoc Lu-Nguyen, et al.
Atherosclerosis|October 22, 2008
Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient miceEyman Osman, Vanessa Evans, Ian R Graham, et al.
Metabolism: Clinical and Experimental|June 29, 2010
Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscleVanessa C Evans, Ian R Graham, Takis Athanasopoulos, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Journal of Cachexia, Sarcopenia and Muscle|May 9, 2019
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)Pradeep Harish, Alberto Malerba, Ngoc Lu-Nguyen, et al.
Nucleic Acids Research|March 18, 2020
G-quadruplex ligands mediate downregulation of DUX4 expressionLukasz Ciszewski, Ngoc Lu-Nguyen, Alex Slater, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 25, 2010
Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx miceAlberto Malerba, Paul S Sharp, Ian R Graham, et al.
Human Gene Therapy|April 2, 2011
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx miceTaeyoung Koo, Alberto Malerba, Takis Athanasopoulos, et al.
Molecular Therapy. Nucleic Acids|December 20, 2012
Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular DystrophyAlberto Malerba, Jagjeet K Kang, Graham McClorey, et al.
Current Gene Therapy|July 11, 2015
Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)Klaudia Kawecka, Michael Theodoulides, Yalin Hasoglu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 29, 2006
APOE epsilon3 gene transfer attenuates brain damage after experimental strokeBarry W McColl, Ailsa L McGregor, Andrew Wong, et al.
Human Molecular Genetics|July 12, 2019
Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1Alberto Malerba, Pierre Klein, Ngoc Lu-Nguyen, et al.
Atherosclerosis|October 22, 2008
Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient miceEyman Osman, Vanessa Evans, Ian R Graham, et al.
Metabolism: Clinical and Experimental|June 29, 2010
Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscleVanessa C Evans, Ian R Graham, Takis Athanasopoulos, et al.
Pageof 11